Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of Breast Cancer

The prognosis depends on whether the breast cancer is localized, regional, or metastatic at the time of diagnosis. 61.4% are diagnosed at the local stage and the 5-year survival for localized female breast cancer is 98.8%. Overall, female breast cancer survival is good and the overall 5-year survival rate for female breast cancer patients during the period 2007-2013 was 90.8%.

However, women who are diagnosed at an advanced age may be more likely than younger women to die of the disease. The number of female breast cancer deaths is highest among women aged 55-64. Female breast cancer is the fourth leading cause of cancer death in the United States. Death rates have been falling on average 1.8% each year over 2005-2014.

In 2014, there were an estimated 3,327,552 women living with female breast cancer in the United States and in 2017 there are an estimated 40,610 women will die of this disease. (1)

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018